Spectral AI (MDAI) Cash from Investing Activities (2021 - 2022)

Spectral AI (MDAI) posted Cash from Investing Activities of $251.2 million for Q4 2022, up 199.29% on a QoQ basis from -$253.0 million in Q1 2021.

Spectral AI (MDAI) Cash from Investing Activities (2021 - 2022) Analysis & Trends

Spectral AI's Cash from Investing Activities history runs 2 years deep, the most recent figure standing at $251.2 million for Q4 2022.

Quarterly Cash from Investing Activities changed N/A year-over-year to $251.2 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $251.2 million (up 199.29% YoY) and the FY2022 annual result came in at $251.6 million, up 199.43% from the prior year.
Cash from Investing Activities was $251.2 million for Q4 2022 at Spectral AI, up from -$253.0 million in the prior quarter.
Across five years, Cash from Investing Activities topped out at $251.2 million in Q4 2022 and bottomed at -$253.0 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Investing Activities (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-20.32 Bn
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-185.00 Mn
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-917.00 Mn
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-591.00 Mn
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-92.80 Mn
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-298.50 Mn
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-2.50 Bn
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-475.32 Mn
10	Spectral AI	52.23 Mn	40.58 Mn	2.03 Mn	-

Download Data